Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow ILLUMINA, INC.

Get SEC filing alerts via email and in your feed for ILLUMINA, INC.

ILMN

ILLUMINA, INC.

About ILLUMINA, INC.

Illumina, Inc. is a global leader in genetic and genomic analysis, providing sequencing and array-based solutions for research, clinical, and applied markets. Its products include instruments, consumables, and analysis tools used in genomics research, diagnostics, and personalized medicine. Serving research institutions, healthcare providers, and biotech companies, Illumina's core value lies in advancing genetic understanding and enabling precision health through innovative, high-throughput sequencing technologies.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from ILLUMINA, INC.

1
1
ILLUMINA, INC. Illumina Reports 4.8% Revenue Growth to $1.091 Billion in Q1 2026

Via official filing (AI summary) | about 1 month ago | 0 comments

2
1
ILLUMINA, INC. Illumina Reports $4.34 Billion Revenue for Fiscal Year 2025, Faces Challenges from Tariffs and Inflation

Via official filing (AI summary) | 4 months ago | 0 comments

3
1
ILLUMINA, INC. Illumina Reports Q3 2025 Revenue of $1.084 Billion, Plans Acquisition of SomaLogic

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
ILLUMINA, INC. Illumina Reports Q2 2025 Revenue Decline to $1.059 Billion, Achieves Net Income Turnaround

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
ILLUMINA, INC. Illumina Reports $1.041 Billion Revenue, Net Income of $131 Million for Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
ILLUMINA, INC. Illumina Reports 3% Revenue Decline to $4.37 Billion for Fiscal Year 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

7
1
ILLUMINA, INC. Illumina Reports Q3 2024 Financial Results with Decreased Revenue and Net Loss, Despite Gross Profit Margin Improvement

Via official filing (AI summary) | over 1 year ago | 0 comments